N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models
BioScience Trends · 2025
DOI: 10.5582/bst.2024.01360 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioScience Trends, 2025. Verfasst von Jun-Sik Kim und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid Precursor Protein Secretases, tau Proteins, Aspartic Acid Endopeptidases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is the most common type of dementia. Its incidence is rising rapidly as the global population ages, leading to a significant social and economic burden. AD involves complex pathologies, including amyloid plaque accumulation, synaptic dysfunction, and neuroinflammation. This study explores the therapeutic potential of N 5 -((perfluorophenyl)amino)glutamine (RA-PF), a derivative of γ-glutamyl-N'-(2-hydroxyphenyl)hydrazide (Ramalin), a compound with antioxidant and anti-inflammatory properties. Administration of RA-PF to 5xFAD mice decreases BACE1, reduces Aβ plaque deposition, inhibits microglial activation, restores synaptic transmission, and improves mitochondrial motility, leading to the recovery of cognitive function. Additionally, RA-PF treatment in 3xTg-AD mice alleviates anxiety-like behaviors, tau phosphorylation via inactivating GSK-3β, and BACE1 expression. Further transcriptomic analysis reveals RA-PF treatment in AD mice models recovers phagosome, inflammation, NOD-like receptor, presynaptic membrane, and postsynaptic membrane related signaling pathways. These findings suggest that RA-PF effectively targets multiple aspects of AD pathology, offering a novel multi-target approach for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
- Department of Neuroscience, Graduate School, Kyung Hee University, Seoul, Korea.
- Division of Polar Life Sciences, Korea Polar Research Institute, Incheon, Korea.
- Bio Research Dept, Ahngook Pharmaceutical Co., Gwacheon, Korea.
- Department of Physiology, School of Medicine, Kyung Hee University, Seoul, Korea.
- Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Zitieren
APA
Kim, J. S., Cho, Y., Lee, J., Cho, H., Han, S., Lee, Y., Jeon, Y., Kim, T. K., Hong, J. M., Im, J., Chae, M., Lee, Y., Kim, H., Park, S. Y., Kim, S. H., Yim, J. H., & Jo, D. G. (2025). N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models. BioScience Trends. https://doi.org/10.5582/bst.2024.01360
Vancouver
Kim JS, Cho Y, Lee J, Cho H, Han S, Lee Y, et al. N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models. BioScience Trends. 2025. doi:10.5582/bst.2024.01360
BibTeX
@article{Kim2025,
author = {Kim, Jun-Sik and Cho, Yongeun and Lee, Jeongmi and Cho, Heewon and Han, Sukmin and Lee, Yeongyeong and Jeon, Yeji and Kim, Tai Kyoung and Hong, Ju-Mi and Im, Jeonghyeong and Chae, Minshik and Lee, Yujeong and Kim, Hyunwook and Park, Sang Yoon and Kim, Sung Hyun and Yim, Joung Han and Jo, Dong-Gyu},
title = {N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models},
journal = {BioScience Trends},
year = {2025},
doi = {10.5582/bst.2024.01360}
}
EUVIMED